Viewing Study NCT03150693


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-01-05 @ 12:50 AM
Study NCT ID: NCT03150693
Status: SUSPENDED
Last Update Posted: 2025-09-05
First Post: 2017-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module